The U.S. digestive health products market size was estimated at USD 15.80 billion in 2025 and projected to reach USD 30.05 billion by 2033, growing at a CAGR of 8.4% from 2026 to 2033. The growth of the U.S. digestive health products market has been driven by rising consumer awareness of the gut-systemic health connection, reinforced by government-published scientific communication and corporate evidence-sharing.
Public agencies such as the National Institutes of Health, through its Human Microbiome Project updates, and initiatives by the U.S. Food and Drug Administration have highlighted the importance of gut microbiota in supporting immunity, metabolic health, and mental well-being. This institutional focus has strengthened consumer trust in clinically validated probiotics, prebiotics, digestive enzymes, and fiber supplements. At the same time, a growing shift toward preventive healthcare has further supported demand. This trend is reflected in 2024 disclosures from Nestlé Health Science and Danone North America, which highlighted an increased emphasis on digestive wellness portfolios to meet rising adoption across U.S. households.
Market trends have also been shaped by consumers’ preference for cleaner and more transparent ingredient sourcing. According to the data published in March 2024, in a survey conducted among 1,257 U.S. shoppers, about 81% claimed it is important to purchase clean-label food products. Over the past 3-4 years, U.S. brands such as Garden of Life, Ritual, and NOW Foods expanded product lines built on traceable, non-GMO, plant-based formulations aligned with sustainability commitments. Retailer-driven standards have further reinforced this clean-label momentum, which has accelerated reformulation toward minimal-additive digestive supplements.
In July 2025, Novonesis announced the publication of a landmark, peer-reviewed review compiling over 400 publications and 200 clinical studies on the BB-12 probiotic, confirming it as one of the most extensively researched strains, with proven benefits for gut survival, immune support, and digestive health outcomes such as bowel regularity. This aligns with growing regulatory and consumer scrutiny around health claims, where companies such as Novonesis (formerly Chr. Hansen) are strengthening differentiation by publishing strain-specific clinical evidence, thereby raising the competitive benchmark for scientifically validated digestive health solutions.
Innovation in the U.S. digestive health products market is thriving, with a focus on advanced formulations and novel ingredients to address consumer concerns and preferences. Probiotics, prebiotics, and enzymes continue to be key areas of innovation, with an emphasis on delivering targeted and effective solutions for digestive well-being. In October 2024, Probi launched a new probiotic concept, Metabolic Health by Probi, targeting key markers of metabolic syndrome with clinically supported strains to improve cardiovascular health, weight management, and overall metabolic function. The solution combines two well-researched strains and is positioned to address rising global metabolic health concerns by offering evidence-based support for gut health, cholesterol, blood pressure, and inflammation.
Companies in the U.S. digestive health products industry are increasingly prioritizing strategic acquisitions to strengthen their global footprint and enhance market competitiveness. In the coming years, leading international players are expected to acquire small- and medium-sized firms within the sector to accelerate regional expansion and solidify their presence in key markets.
In the U.S. digestive health products industry, regulatory bodies establish strict guidelines governing product formulation and ingredient composition to ensure safety and efficacy. Compliance with these standards is essential, with regulations often specifying permissible levels of probiotics, prebiotics, and other active components. At the same time, some consumers opt for natural alternatives, such as fiber-rich foods, fermented products, and probiotic-rich yogurts as substitutes for digestive health supplements, influencing overall market dynamics.
The U.S. digestive health products market is being driven by rising consumer demand for clinically validated supplements that support gut health, immunity, and digestive comfort. Consumers increasingly seek targeted solutions for bloating, IBS, and microbiome balance rather than general wellness products. Trusted brands, convenient formats such as gummies and capsules, and clean-label options further influence purchasing decisions. Strong marketing, digital visibility, and alignment with health-focused lifestyles continue to boost adoption across all age groups. Reflecting this trend, in March 2026, Nature Made expanded its digestive health portfolio with new gut-focused products, including SuperGreens Powder, SuperGreens Capsules, and Digestive Enzymes, designed to support overall digestive wellness.
This product will be delivered within 1-3 business days.
Public agencies such as the National Institutes of Health, through its Human Microbiome Project updates, and initiatives by the U.S. Food and Drug Administration have highlighted the importance of gut microbiota in supporting immunity, metabolic health, and mental well-being. This institutional focus has strengthened consumer trust in clinically validated probiotics, prebiotics, digestive enzymes, and fiber supplements. At the same time, a growing shift toward preventive healthcare has further supported demand. This trend is reflected in 2024 disclosures from Nestlé Health Science and Danone North America, which highlighted an increased emphasis on digestive wellness portfolios to meet rising adoption across U.S. households.
Market trends have also been shaped by consumers’ preference for cleaner and more transparent ingredient sourcing. According to the data published in March 2024, in a survey conducted among 1,257 U.S. shoppers, about 81% claimed it is important to purchase clean-label food products. Over the past 3-4 years, U.S. brands such as Garden of Life, Ritual, and NOW Foods expanded product lines built on traceable, non-GMO, plant-based formulations aligned with sustainability commitments. Retailer-driven standards have further reinforced this clean-label momentum, which has accelerated reformulation toward minimal-additive digestive supplements.
In July 2025, Novonesis announced the publication of a landmark, peer-reviewed review compiling over 400 publications and 200 clinical studies on the BB-12 probiotic, confirming it as one of the most extensively researched strains, with proven benefits for gut survival, immune support, and digestive health outcomes such as bowel regularity. This aligns with growing regulatory and consumer scrutiny around health claims, where companies such as Novonesis (formerly Chr. Hansen) are strengthening differentiation by publishing strain-specific clinical evidence, thereby raising the competitive benchmark for scientifically validated digestive health solutions.
Innovation in the U.S. digestive health products market is thriving, with a focus on advanced formulations and novel ingredients to address consumer concerns and preferences. Probiotics, prebiotics, and enzymes continue to be key areas of innovation, with an emphasis on delivering targeted and effective solutions for digestive well-being. In October 2024, Probi launched a new probiotic concept, Metabolic Health by Probi, targeting key markers of metabolic syndrome with clinically supported strains to improve cardiovascular health, weight management, and overall metabolic function. The solution combines two well-researched strains and is positioned to address rising global metabolic health concerns by offering evidence-based support for gut health, cholesterol, blood pressure, and inflammation.
Companies in the U.S. digestive health products industry are increasingly prioritizing strategic acquisitions to strengthen their global footprint and enhance market competitiveness. In the coming years, leading international players are expected to acquire small- and medium-sized firms within the sector to accelerate regional expansion and solidify their presence in key markets.
In the U.S. digestive health products industry, regulatory bodies establish strict guidelines governing product formulation and ingredient composition to ensure safety and efficacy. Compliance with these standards is essential, with regulations often specifying permissible levels of probiotics, prebiotics, and other active components. At the same time, some consumers opt for natural alternatives, such as fiber-rich foods, fermented products, and probiotic-rich yogurts as substitutes for digestive health supplements, influencing overall market dynamics.
The U.S. digestive health products market is being driven by rising consumer demand for clinically validated supplements that support gut health, immunity, and digestive comfort. Consumers increasingly seek targeted solutions for bloating, IBS, and microbiome balance rather than general wellness products. Trusted brands, convenient formats such as gummies and capsules, and clean-label options further influence purchasing decisions. Strong marketing, digital visibility, and alignment with health-focused lifestyles continue to boost adoption across all age groups. Reflecting this trend, in March 2026, Nature Made expanded its digestive health portfolio with new gut-focused products, including SuperGreens Powder, SuperGreens Capsules, and Digestive Enzymes, designed to support overall digestive wellness.
U.S. Digestive Health Products Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, the analyst has segmented the U.S. digestive health products market report on the basis of product and ingredient.Product Outlook (Revenue, USD Billion, 2021-2033)
- Dairy Products
- Bakery & Cereals
- Non-Alcoholic Beverages
- Supplements
- Others
Ingredient Outlook (Revenue, USD Billion, 2021-2033)
- Prebiotics
- Probiotics
- Food Enzymes
- Animal-Based
- Plant-Based
- Microbial-Based
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Digestive Health Products Market Variables and Trends
Chapter 4. U.S. Digestive Health Products Market: Consumer Behavior Analysis
Chapter 5. U.S. Digestive Health Products Market: Product Estimates & Trend Analysis
Chapter 6. U.S. Digestive Health Products Market: Ingredient Estimates & Trend Analysis
Chapter 7. U.S. Digestive Health Products Market: Competitive Analysis
List of Tables
List of Figures
Companies Mentioned
- Bayer AG
- Procter & Gamble
- NOW Foods Inc.
- Nature Made
- Amway
- Herbalife Nutrition
- Nature’s Bounty
- Garden of Life
- Renew Life
- Seed Health, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 109 |
| Published | April 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 15.8 Billion |
| Forecasted Market Value ( USD | $ 30.05 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | United States |
| No. of Companies Mentioned | 10 |
